NEW YORK (GenomeWeb News) — Empire Genomics and BioDiscovery will integrate and co-market certain of their products for the array comparative genomic hybridization market, BioDiscovery said Wednesday. 
 
Empire Genomics, a Buffalo, NY-based start-up, specializes in molecular karyotyping technology in an aCGH platform that is used to quantify “changes in chromosomal abnormalities,” BioDisovery said.
 
BioDiscovery will provide image and aCGH software to the partnership.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.